 Shares of ProQR Therapeutics NV PRQR, 1.85 soared 56.3 in premarket trading on Thursday after the company said it expanded an RNA editing deal with Eli Lilly Co. Inc. LLY, 2.33 aimed at making new genetic medicines. The companies had first said they would collaborate in 2021. 